why choose us

First received: October 26, 2023

Clinical Trial: CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Thyroid Nodule (Benign)

Study Type: INTERVENTIONAL


Official Title: First Clinical Feasibility Study Using the CellFX® Percutaneous Electrode (PE) System for the Treatment of Symptomatic Benign Thyroid Nodules

Brief Summary: The objective of this clinical feasibility study is to evaluate initial clinical safety and device performance of the CellFX Percutaneous Electrode (PE) System for the treatment of symptomatic benign thyroid nodules.

Read more